Therefore, aberrant TIMP3 DNA methylation in AML patients could be associated with an adverse genetic and cytogenetic prognosis, specifically with the presence of trisomy 11 and deletions linked to TP53 pro-oncogene loss. Here, TIMP3 is linked to acute myeloid leukemia.